Yukinobu Goto

Prof. Dr. Yukinobu Goto

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2013 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
SUShingo Usui
Shingo Usui
MYMasatoshi Yamaoka
Masatoshi Yamaoka
HSHisashi Suzuki
Hisashi Suzuki
SKShinji Kikuchi
Shinji Kikuchi
YGYukinobu Goto
Yukinobu Goto
NKNaohiro Kobayashi
Naohiro Kobayashi
Background Hyponatremia is the most common electrolyte disorder and is a negative prognostic factor in several kinds of cancer. However, few reports have referred to hyponatremia in non-small cell lung cancer (NSCLC). In the present study, the authors examined the influence of preoperative serum sodium concentration on survival in completely resected NSCLC. Methods A total of 386 completely resected NSCLC patients were retrospectively analyzed. Results Kaplan-Meier survival curves showed that serum sodium concentration was a significant prognostic factor, and the log-rank statistical value was maximum (9.173, p = 0.002) when the cutoff value of serum sodium concentration was 139 mEq/L. The overall 5-year survival rate of the high-serum sodium concentration group (> 139 mEq/L) was 74.8% and that of the low-serum sodium concentration group (≤ 139 mEq/L) was 59.7%. Clinicopathological factors showed significant differences between the two groups for leukocyte count, neutrophil count, C-reactive protein, tumor size, and pleural invasion. Conclusions Low-serum sodium concentration, which was associated with tumor status and inflammation, had negative prognostic influence in completely resected NSCLC.

3 October 2018 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
YGYukinobu Goto
Yukinobu Goto
YHYuji Hiramatsu
Yuji Hiramatsu
NANaohide Ageyama
Naohide Ageyama
SSShoko Sato
Shoko Sato
Bryan MathisBryan Mathis
Bryan Mathis
YSYukio Sato
Yukio Sato

26 December 2013 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
YGYukinobu Goto
Yukinobu Goto
YHYuji Hiramatsu
Yuji Hiramatsu
NANaohide Ageyama
Naohide Ageyama
SSShoko Sato
Shoko Sato
SKShinya Kanemoto
Shinya Kanemoto
YSYuzuru Sakakibara
Yuzuru Sakakibara

1 January 2018 in The Journal of the Japanese Association for Chest Surgery
Verified
Journal Article
Closed access
MYMasatoshi Yamaoka
Masatoshi Yamaoka
SKShinji Kikuchi
Shinji Kikuchi
TYTakahiro Yanagihara
Takahiro Yanagihara
MSMitsuaki Sakai
Mitsuaki Sakai
YGYukinobu Goto
Yukinobu Goto
YSYukio Sato
Yukio Sato

25 November 2013 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
SMSei Morizumi
Sei Morizumi
YHYuji Hiramatsu
Yuji Hiramatsu
KMKanji Matsuzaki
Kanji Matsuzaki
YGYukinobu Goto
Yukinobu Goto
SSShoko Sato
Shoko Sato
YSYuzuru Sakakibara
Yuzuru Sakakibara
We tested the hypothesis that heparin administration prior to the emergence of tissue factor (TF) would increase plasma TF pathway inhibitor (TFPI) and attenuate TF-mediated thrombin generation during simulated cardiopulmonary bypass (CPB). Human blood was recirculated for 120 minutes using an oxygenator and roller pump. Four groups were examined: control group (heparin 3.75 U/mL, in donor blood, n = 7), rTF group (heparin + recombinant TF 1000 pg/mL, in donor blood, n = 7), TFPI boost group (heparin, in preheparinized donor blood, n = 8), and rTF + TFPI boost group (heparin + rTF, in preheparinized blood, n = 7). In the two TFPI boost groups, 50 U/kg of heparin was given to the donors intravenously five minutes before donation to boost plasma TFPI levels. Total plasma TFPI, thrombin-antithrombin complex, and prothrombin fragment F1+2 levels were measured before and during CPB. Preheparinization increased total plasma TFPI levels by a factor of 8.0. Administration of rTF significantly enhanced the generation of F1+2 (p = 0.0002). The heparin-induced TFPI elevation reduced both thrombin-antithrombin complex and F1+2 to control levels in rTF + TFPI boost group (p = 0.0158 for thrombin-antithrombin complex, p < 0.0001 for F1+2 ). F1+2 levels were at all times lower than control levels in TFPI boost group (p < 0.0001). Heparin-induced TFPI elevation attenuates TF-mediated thrombin generation. Early heparin administration prior to the emergence of plasma TF may represent a novel strategy for controlling thrombin generation by the extrinsic coagulation pathway during CPB.

24 November 2025 in Advances in Respiratory Medicine
Verified
Journal Article
Open access
PDF file
NMNaoki Maki
Naoki Maki
TYTakahiro Yanagihara
Takahiro Yanagihara
AWAshoka Wijesinghe
Ashoka Wijesinghe
KSKazuto Sugai
Kazuto Sugai
TKTomoyuki Kawamura
Tomoyuki Kawamura
YSYukio Sato
Yukio Sato
Introduction: Minimally invasive video-assisted thoracic surgery (VATS) for lung cancer has become a widely used approach. However, postoperative pulmonary complications (PCs) such as pneumonia, atelectasis, and lung fistula remain significant challenges, particularly in older adult patients with multiple comorbidities. The 6-minute walk test (6MWT) has been suggested as a predictor of postoperative outcomes in various surgical settings, but its relationship with postoperative complications following VATS lobectomy for lung cancer has not been thoroughly explored. The aim of this study was to determine if preoperative 6MWD predicted the occurrence of 30-day PCs among patients undergoing VATS lobectomy for non-small-cell lung cancer. Methods: This retrospective study examined 66 patients who underwent VATS lobectomy for lung cancer. Participants were categorized into two groups: those with postoperative pulmonary complications (n = 11) and those without (n = 55). The research period was from January to September 2022. The preoperative 6MWT distance, along with other clinical and demographic factors, was assessed to determine its predictive value for postoperative complications. Multivariate logistic regression analysis was performed to identify significant predictors. Results: The study found that preoperative 6MWT ≤ 450 m was a significant predictor of postoperative pulmonary complications (odds ratio: 5.674, 95% CI: 1.206–26.684, p = 0.028). Conclusions: The preoperative 6MWT distance is a useful predictor of postoperative pulmonary complications in patients undergoing VATS lobectomy for lung cancer. Patients with a 6MWT ≤ 450 m may be at higher risk for complications such as pneumonia, atelectasis, and lung fistula. Incorporating preoperative 6MWT as a risk stratification tool could help guide clinical decisions and rehabilitation efforts to improve postoperative outcomes in this patient population.